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AbstrACt
Objective Previous research suggests that some 
adolescents are using e-cigarette devices to 
vaporise (‘vaping’) cannabis in the form of hash oil, 
tetrahydrocannabinol (THC) wax or oil, or dried cannabis 
buds or leaves. However, it is unclear how adolescents 
who vape cannabis use other tobacco products. This 
study examined the extent to which adolescents reported 
ever vaping cannabis and investigated how demographic 
variables and tobacco behaviours were associated with 
use.
Design We used cross-sectional data from adolescents 
(total response rate 64.5%) who participated in the 
2017 North Carolina Youth Tobacco Survey. SAS logistic 
regression survey procedures were used to account for the 
complex survey design and sampling weights.
setting North Carolina, USA.
Participants Adolescents in high school (n=2835).
Primary outcome and measure Adolescents were asked 
to indicate whether they had ever used an e-cigarette 
device with marijuana, THC or hash oil, or THC wax.
results Approximately 1 in 10 high school students 
reported ever vaping cannabis in the overall sample 
(9.6%). In multivariable models, adolescents who 
reported using cigars (adjusted OR (aOR) 3.76, 95% CI 
2.33 to 6.07), waterpipe (aOR 2.32, 95% CI 1.37 to 3.93) 
or e-cigarettes (aOR 3.18, 95% CI 2.38 to 4.25) in the 
past 30 days had higher odds of reporting ever vaping 
cannabis compared with their counterparts. There was no 
significant association between use of smokeless tobacco 
(aOR 0.89, 95% CI 0.42 to 1.91) or use of cigarettes (aOR 
1.27, 95% CI 0.71 to 2.29) in the past 30 days and odds of 
reporting ever vaping cannabis.
Conclusions These findings provide evidence that 
large numbers of high school students who use tobacco 
products have vaped cannabis. As tobacco control 
policies—such as communication campaigns or smoke-
free laws—increasingly focus on e-cigarettes, attention to 
understanding how adolescents use e-cigarettes to vape 
substances other than nicotine is essential.
IntrODuCtIOn
Although the prevalence of e-cigarette use 
among youth has increased dramatically in 
the past decade,1 little epidemiologic data 
exist on the prevalence of using e-cigarette 
devices or other specialised devices to vapo-
rise (‘vape’) cannabis in the form of hash 
oil, tetrahydrocannabinol (THC) wax or 
oil, or dried cannabis buds or leaves.2 This 
is surprising given that (1) cannabis (also 
referred to as marijuana) and e-cigarettes 
are the most commonly used substances by 
adolescents in the USA,3 (2) evidence exists 
that adolescents dual use both tobacco e-cig-
arettes and cannabis,4 and (3) longitudinal 
research suggests that use of e-cigarettes 
is associated with progression to use of 
cannabis.5 
A growing number of studies have exam-
ined prevalence of vaping cannabis among 
adults6–8 and adolescents9–11 in the USA. 
For example, a recent study used data from 
the 2016 National Youth Tobacco Survey 
(NYTS) and found that 8.9% of middle and 
high school students reported ever vaping 
cannabis.10 Additionally, the researchers 
found that prevalence was higher among 
current e-cigarette users (39.5%) and 
current non-e-cigarette tobacco product 
users (38.5%).9 10 Other studies have been 
strengths and limitations of this study
 ► Our measure of vaping cannabis has been used
previously in nationally representative surveys in
the USA. 
 ► Results can only be  generalised to adolescents in a
specific US  state (North Carolina). 
 ► The survey did not assess frequency or current use
of vaping cannabis.
 ► The survey did not provide relevant examples of
products used to vape cannabis (eg, ‘JuJu Point’ or
‘Pax’).
 ► We were unable to assess whether participants used 
tobacco e-cigarettes for cannabis or specialised
cannabis devices.
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conducted in Connecticut9 and California11 and found 
similar prevalence estimates. While all studies have exam-
ined how demographic factors were associated with prev-
alence of vaping cannabis,9–11 and one study examined 
how current e-cigarette and other tobacco product use 
was associated with prevalence of vaping cannabis,10 no 
studies to our knowledge have examined how adolescents 
who vape cannabis use other specific tobacco products 
(ie, cigarettes, cigars, waterpipe, smokeless tobacco).
The US Food and Drug Administration (FDA) can now 
regulate the manufacture, marketing, sale and distribu-
tion of e-cigarettes and their components, including e-liq-
uids, cartridges, flavourings and batteries.12 Future FDA 
regulations for e-cigarettes may take years to implement 
across the USA; however, there is significant variation in 
state and local e-cigarette policies,13 as well as state poli-
cies related to legal access to cannabis. Therefore, to 
provide evidence on how youth use e-cigarettes to vape 
cannabis, which can be useful to state and local author-
ities, we examined the prevalence of vaping cannabis 
among adolescents in North Carolina—a state that 
has not legalised medical or retail cannabis for adults. 
Extending previous research, we examined demographic 
variables and tobacco behaviours associated with use.
MethODs
settings, participants, procedures
We used data from the 2017 North Carolina Youth Tobacco 
Survey (NCYTS). Similar to the NYTS,14 the NCYTS is 
a public and charter school-based survey of students in 
grades 6–12. A multi-stage cluster sampling design in 
three distinct regions of the state was used. School districts 
were first selected within three geographic regions of the 
state; a school’s probability for selection was proportional 
to its enrolment size for the survey year. Classes were then 
randomly selected within each school. Participation was 
voluntary and anonymous. Passive consent forms were 
utilised, unless an active consent form was required 
according to a specific school district policy. Our analyses 
focused on data from high school students. The overall 
response rate was 64.5% (75.2% school response rate, 
85.8% student response rate), which is similar to the 
response rate from the 2016 NYTS survey (71.6%).15
Measures
Vaping cannabis
Our main outcome of interest was whether adoles-
cents had used e-cigarette devices to vape cannabis. 
Our measure of ever vaping cannabis came from the 
2016 NYTS survey.10 Adolescents were asked, ‘Have you 
ever used an e-cigarette device with a substance besides 
nicotine?’ Participants could choose one or more of 
the following response options: (1) Yes, I have used an 
e-cigarette device with marijuana, THC or hash oil, or
THC wax; (2) Yes, I have used an e-cigarette device with
another substance that is not marijuana, THC or hash
oil, or THC wax; (3) No, I have only used an e-cigarette
device with nicotine; (4) No, I have never used an e-ciga-
rette device; and (5) Don’t know/not sure. If participants 
selected ‘Yes’ to the first response option, they were 
coded as having vaped cannabis. Adolescents selecting 
any other response option were coded as never having 
vaped cannabis.
In a previous section of the survey, e-cigarettes were 
described as: “battery powered devices that usually 
contain a nicotine-based liquid that is vaporised and 
inhaled. You may know them as vape-pens, hookah-pens, 
e-hookahs, e-cigars, e-pipes, personal vaporizers or mods.
Some brand examples include NJOY, Blu, Vuse, MarkTen,
Logic, Vapin Plus, eGo and Halo.”
Tobacco use
The survey assessed ever and past 30 days use of five 
tobacco products, including: (1) cigarettes, (2) cigars 
(including cigars, little cigars, and cigarillos), (3) smoke-
less tobacco (SLT) (including chewing tobacco, snuff, or 
dip; snus; and dissolvable tobacco products), (4) water-
pipe (ie, hookah), and (5) e-cigarettes. Using this infor-
mation, adolescents were classified as current users of 
that tobacco product if they indicated that they had ever 
used the product and reported using it on at least 1 day 
in the past 30 days. Otherwise, participants were coded as 
non-current tobacco users of the product.
Demographics
Demographic variables included sex (female or male), 
grade (9th, 10th, 11th, or 12th), race/ethnicity cate-
gorised into non-Hispanic white, non-Hispanic black, 
Hispanic, or non-Hispanic other race, and whether 
students reported receiving free or reduced-price lunch 
at school (yes or no).
statistical analysis
Of the 3133 high school students, we dropped data for 
62 participants (2%) who had missing or inconsistent 
responses to whether they had vaped cannabis or not and 
data for 236 participants (7.5%) who had missing data on 
any of the other variables examined, creating an analytic 
sample of 2835 participants. We first examined correlates 
of vaping cannabis using bivariate χ2 tests. We then 
conducted a multivariable logistic regression, including 
correlates from the bivariate analyses with p<0.10—an 
approach that has been used in previous research.16 
Collinearity among the tobacco use variables and demo-
graphic characteristics was low, with variance inflation 
factor values <2 for all independent variables. Correla-
tions among tobacco use variables, calculated using phi 
coefficients which are measures of association between 
dichotomous variables, ranged from 0.20 to 0.47. Anal-
yses used SAS version 9.4 survey procedures (SAS Inc, 
Cary, NC, USA). We set critical α=0.05 and used two-tailed 
statistical tests. Results include weighted percentages, 
adjusted odds ratios (aOR) and 95% confidence intervals 
(95% CI).
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Participant involvement
This research was done without participant involvement. 
Participants were not invited to comment on the study 
design and were not consulted to develop patient rele-
vant outcome. Participants were not invited to contribute 
to the writing or editing of this document for readability 
or accuracy. However, there are plans to disseminate 
the results of the research to North Carolina residents, 
through website materials and infographics of results.
results
Approximately 1 in 10 adolescents reported ever vaping 
cannabis in the overall sample (9.6%) (table 1), which 
was a majority non-Hispanic white (52.8%) and evenly 
distributed by sex and grade. Ever vaping cannabis was 
significantly associated with sex, grade and race in bivar-
iate results. Specifically, prevalence was significantly 
higher among males (11.0%) compared with females 
(8.2%) (p=0.04). In addition, grade was associated with 
Table 1 Weighted participant characteristics stratified by ever vaping cannabis status, n=2835; data collected from the 2017 




Has never vaped 
cannabis, n=2582
% (n)
Has ever vaped 
cannabis, n=253
% (n) P value
Ever used an e-cigarette to vape cannabis
 No 90.4 (2582) – – 
 Yes 9.6 (253) – – 
Sex
 Female 51.2 (1428) 91.8 (1323) 8.2 (105) 0.04
 Male 48.8 (1407) 89.0 (1259) 11.0 (148)
Grade
 9th 28.7 (904) 95.3 (856) 4.7 (48) <0.001
 10th 26.2 (696) 90.9 (638) 9.1 (58)
 11th 24.0 (577) 89.4 (515) 10.6 (62)
 12th 21.0 (658) 84.5 (573) 15.5 (85)
Race
 Non-Hispanic white 52.8 (1503) 88.7 (1352) 11.3 (151) 0.02
 Non-Hispanic black 26.0 (650) 95.0 (617) 5.0 (33)
 Hispanic 14.1 (517) 89.5 (468) 10.5 (49)
 Non-Hispanic other 7.2 (167) 88.2 (145) 11.8 (20)
Free or reduced-price lunch
 Yes 44.1 (1362) 90.1 (1249) 9.9 (113) 0.73
 No 55.9 (1473) 90.7 (1333) 9.3 (140)
Current cigarette use
 No 92.7 (2617) 92.2 (2436) 7.8 (181) <0.001
 Yes 7.3 (218) 67.8 (146) 32.2 (72)
Current cigar use
 No 88.9 (2497) 93.6 (2346) 6.4 (151) <0.001
 Yes 11.1 (338) 65.2 (236) 34.8 (102)
Current smokeless tobacco use
 No 94.3 (2649) 91.6 (2451) 8.4 (198) <0.001
 Yes 5.7 (186) 71.7 (131) 28.3 (55)
Current waterpipe use
 No 96.6 (2722) 91.6 (2516) 8.4 (206) <0.001
 Yes 3.4 (113) 57.0 (66) 43.0 (47)
Current tobacco e-cigarette use
 No 84.2 (2334) 94.2 (2217) 5.8 (117) <0.001
 Yes 15.8 (501) 70.7 (365) 29.3 (136)
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prevalence of ever vaping cannabis (p<0.001), such that 
as grade increased, prevalence of ever vaping cannabis 
increased. Specifically, the prevalence among 9th 
grade students was 4.7% while the prevalence among 
12th grade students was 15.5%. Prevalence was higher 
among non-Hispanic white students (11.3%), Hispanic 
students (10.5%), and non-Hispanic other students 
(11.8%), compared with non-Hispanic black students 
(5.0%) (p=0.02). Finally, prevalence was significantly 
higher among adolescents who reported using ciga-
rettes, cigars, SLT, waterpipe or tobacco e-cigarettes 
in the past 30 days (ranging from 28.3% among those 
using SLT to 43.0% among those using waterpipe), all 
p values <0.001.
In multivariable models (table 2), 10th grade students 
(aOR 1.87, 95% CI 1.01 to 3.47), 11th grade students 
(aOR 1.99, 95% CI 1.21 to 3.26),and 12th grade students 
(aOR 2.88, 95% CI 1.46 to 5.67) had higher odds of ever 
vaping cannabis than 9th grade students. In addition, 
adolescents who reported using cigars (aOR 3.76, 95% CI 
2.33 to 6.07), waterpipe (aOR 2.32, 95% CI 1.37 to 3.93) 
or tobacco e-cigarettes (aOR 3.18, 95% CI 2.38 to 4.25) in 
the past 30 days had higher odds of reporting ever vaping 
cannabis than adolescents not using those products in the 
past 30 days. There was no significant association between 
use of SLT (aOR 0.89, 95% CI 0.42 to 1.91) or use of ciga-
rettes (aOR 1.27, 95% CI 0.71 to 2.29) in the past 30 days 
and odds of reporting ever vaping cannabis.
DIsCussIOn
This is one of a growing number of research studies to 
show that many high school students who use tobacco 
products have vaped cannabis. Compared with previous 
research, we found a similar prevalence of vaping 
cannabis among adolescents: 9.6% in our study of North 
Carolina high school students who were mostly between 
the ages of 14–18 years, compared with 5.4% in a sample 
of high school students in Connecticut,98.2% in a sample 
of high school students in Canada aged 15–18,17 8.9% in a 
sample of middle and high school students in the USA,10 
and 10.5% in a sample of 10th graders in California11 
in previous research). Using current North Carolina 
enrolment figures, our findings suggest that over 46 000 
high school students across the state have ever vaped 
cannabis. Moreover, in some sub-groups (ie, current 
waterpipe users), prevalence of ever vaping cannabis rose 
to 43%. These findings provide additional evidence that 
large numbers of adolescents—particularly those who 
currently use tobacco—are also vaping cannabis, even in 
areas where cannabis use is not legal for any adult.
The health effects of vaping cannabis are not yet 
known. Some research suggests that vaping cannabis 
may be associated with fewer respiratory symptoms than 
smoking cannabis.2 18 However, this does not mean that 
adolescents’ use of vaporised cannabis is safe19—particu-
larly if it leads to earlier initiation of tobacco or cannabis 
use, concomitant tobacco and cannabis use, increased 
frequency of use or misuse of tobacco or cannabis, or 
increased potency of cannabis.2 8 19 In addition, there 
are also concerns that qualities of non-combustible 
forms of cannabis (eg, availability of flavourings, no 
smell of smoke, lower harm perceptions) may attract 
youth who would otherwise not use combustible forms of 
cannabis. In a study of 10th graders in Los Angeles, Cali-
fornia, researchers found that 7.8% had never smoked 
combustible cannabis but had used vaporised or edible 
cannabis.11 It is possible that these adolescents would 
never have used cannabis if non-combustible forms of 
cannabis had not been available, although no research, 
to our knowledge, has examined this hypothesis. As has 
been done with e-cigarettes,20 more research and simula-
tion models are needed to quantify the population-level 
benefits and harms of non-combustible forms of cannabis, 
including the effects of vaporised cannabis use, combus-
tible cannabis use, and use of other tobacco products. 
In other words, can vaporised cannabis divert adolescents 
from smoking cannabis, does the availability and accept-
ability of vaporised cannabis attract new adolescents to 
begin using cannabis who would not have otherwise used 
it, and does vaporised cannabis influence other tobacco 
use, including tobacco e-cigarette use?
Recent data from Monitoring the Future, a large study 
of youth and young adults in the USA, suggest that 
prevalence of vaping cannabis increased from 2017 to 
2018 among 8th graders, 10th graders and 12th grad-
ers.21p76 This finding, coupled with the number of high 
school students who have used an e-cigarette device to 
Table 2 Weighted multivariable logistic regression results, 
*†n=2835; data collected from the 2017 North Carolina 
Youth Tobacco Survey
Variable aOR (95% CI)
Male (ref female) 1.33 (0.87 to 2.04)
10th grade (ref 9th grade) 1.87 (1.01 to 3.47)
11th grade (ref 9th grade) 1.99 (1.21 to 3.26)
12th grade (ref 9th grade) 2.88 (1.46 to 5.67)
Black (ref non-Hispanic white) 0.51 (0.22 to 1.16)
Hispanic (ref non-Hispanic white) 1.03 (0.78 to 1.38)
Other race (ref non-Hispanic white) 1.38 (0.72 to 2.64)
Current cigarette use (ref no current 
use)
1.27 (0.71 to 2.29)
Current cigar use (ref no current use) 3.76 (2.33 to 6.07)
Current smokeless tobacco use (ref no 
current use)
0.89 (0.42 to 1.91)
Current waterpipe use (ref no current 
use)
2.32 (1.37 to 3.93)
Current tobacco e-cigarette use (ref no 
current use)
3.18 (2.38 to 4.25)
*Only variables that were statistically significant (p<0.10) in
bivariate analyses were included in the multivariable model (ie, sex,
grade, race, current use of cigarettes, cigars, smokeless tobacco,
waterpipe, or e-cigarettes, and ever use of e-cigarettes).
†Bold text indicates significance p<0.05.
5Kowitt SD, et al. BMJ Open 2019;9:e028535. doi:10.1136/bmjopen-2018-028535
Open access
vape cannabis in the current study, is concerning to the 
researchers. Many tobacco control policies and interven-
tions, such as smoke-free laws, do not extend to e-ciga-
rettes,22 let alone using e-cigarettes for other substances, 
such as cannabis. Even though some states, such as 
Colorado, have included cannabis in smoke-free laws,23 
these laws do not cover vaping or vaping cannabis.24 As 
tobacco control policies—such as national communica-
tion campaigns25 or smoke-free laws22—begin focusing on 
e-cigarettes, attention to how e-cigarettes can be used for
use of other substances is warranted. As more states and
countries around the world begin to legalise marijuana
for medicinal and recreational purposes, lessons learned
from tobacco and alcohol regulation should be applied.26
Moreover, since many people believe that vaping 
cannabis is a safer way to use cannabis than other modes of 
administration (eg, smoking),2 communication messages 
on actual safety should be reported. While these data are 
not yet available, two countries—Uruguay and Canada—
have already legalised cannabis for recreational purposes, 
although neither country has legalised sales of non-com-
bustible forms of cannabis yet. In addition, among the US 
states that have legalised medical marijuana for adults, 
Utah legalised only non-combustible forms of marijuana, 
including vaporised cannabis and edibles.27 Findings 
from legalisation in these areas, which represent large-
scale naturalised experiments, will offer insights into the 
safety of cannabis, effects of legalisation on use and/or 
other public health implications of legalisation (eg, prev-
alence of car accidents). Data from Utah, in particular, 
may be useful for answering research questions on trends, 
correlates and consequences of non-combustible forms of 
cannabis (ie, vaporised cannabis).
limitations
Some limitations of the data exist. First, the survey 
included only one item to assess vaping cannabis, did not 
assess frequency of or current use of vaping cannabis, 
did not provide examples of specific products used to 
vape cannabis (eg, ‘JuJu Joint’ or ‘Pax’), and did not 
assess current or ever use of cannabis without an e-cig-
arette device. Given these limitations, we were unable to 
examine more complex patterns of vaping cannabis, such 
as: prevalence and frequency of vaping cannabis in the 
past 30 days, the prevalence of vaping cannabis among 
cannabis users, and cannabis-related variables (eg, harm 
perceptions of cannabis) that could be associated with 
vaping cannabis. Future analyses using larger datasets in 
the USA, such as Monitoring the Future, and worldwide 
could help answer research questions that the current 
study was not able to assess.
Second, the item used to assess prevalence of vaping 
cannabis asked about use of an ‘e-cigarette device with 
marijuana, THC or hash oil, or THC wax’. We are there-
fore unable to assess whether participants used tobacco 
e-cigarettes for cannabis or whether they used specialised
cannabis devices. Relatedly, while the item used to assess
prevalence of vaping cannabis in our study has been
used previously in nationally representative surveys,10 no 
studies, to our knowledge, have used observational or 
biological indicators to verify reports of vaping cannabis.
Third, before the question about ever vaping cannabis, 
the survey defined what an e-cigarette device was and 
provided examples of brand names (NJOY, MarkTen). 
This list did not include JUUL as an e-cigarette brand 
name, which is an important limitation given that JUUL 
became the most popular e-cigarette by the end of 2017,28 
and the description of e-cigarettes did not include any 
cannabis vaporisers.
Fourth, it is possible that students included in the 
final sample with complete data differed from those 
not included in the final sample. Indeed, in an attrition 
analysis (see online supplementary table A), we found 
that a higher proportion of females, non-Hispanic white 
adolescents and non-current tobacco product users were 
included in the final sample.
Fifth, all data were self-reported and subject to related 
biases. For example, given that cannabis use is illegal in 
North Carolina for adults and adolescents, it is possible 
that our prevalence estimate of ever vaping cannabis is 
conservative.
Finally, results can only be generalisable to adolescents 
in a specific state (North Carolina).
COnClusIOns
Findings suggest that adolescent cannabis vaping is an 
important public health issue that is likely to affect and 
be affected by tobacco control and cannabis policies 
in states and at the federal level in the USA.29 In North 
Carolina, three different bills were introduced to make it 
legal for adults to possess medical cannabis in 2017.30–32 
While each of the bills were ultimately defeated, our study 
among North Carolina high school students is relevant 
for subsequent legislative initiatives in North Carolina. 
Increased research investigating how youth use e-ciga-
rette devices for other purposes beyond vaping nicotine, 
like the current study, is needed.
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